News
Amid rising prescription drug prices, local pharmacists are questioning federal efforts—like Donald Trump's executive order to lower costs—warning it could have unintended consequences.
Opinion
5hOpinion
The Daily Caller on MSNDems Who Clapped Like Seals For Biden’s Big Pharma Actions Do 180 On Trump Drug Pricing OrderCongressional Democrats who praised former President Joe Biden’s executive actions against America’s pharmaceutical industry are holding their praise for President Trump’s latest executive order.
Toward the end of his first Administration, Trump signed a similar Executive Order aimed at lowering the prices of some drugs ...
This is misleading. Prices for most prescription drugs — unbranded generics are the exception — are higher in the U.S. than ...
According to the timeline laid out in President Donald Trump’s May 12 executive order, prescription drug price reductions would not happen "almost immediately." The order specifies a 30-day period to ...
9hOpinion
The Daily Caller on MSNMark Halperin Tells Charlie Kirk What He Thinks Is ‘Arguably’ Media’s ‘Biggest Mistake’ In Covering TrumpPolitical analyst Mark Halperin told Turning Point USA founder Charlie Kirk Wednesday that he believes the media makes a ...
President Donald Trump's plans to dramatically slash drug prices for Americans could make Swiss pharmaceutical giant Roche ...
U.S. President Donald Trump's executive order on drug pricing threatens Roche's planned $50 billion investment in the United ...
President Donald Trump's executive order on drug pricing could potentially jeopardize Roche's extensive $50 billion ...
The executive order would require other countries to pay more for medications so that Americans could pay less. But experts ...
14h
The Mirror US on MSNDonald Trump says he's invented 'new word' but everyone points out same thingDonald Trump told reporters he had created a new word as he discussed his plans to lower drug prices in the US - but people ...
President Donald Trump’s latest bid to slash prescription drug prices has once again stirred heated debate about the high costs paid by U.S. patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results